Davy, M.; Genest, L.; Legrand, C.; Pelouin, O.; Froget, G.; Castagné, V.; Rupp, T.
Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models. Cancers 2023, 15, 4478.
https://doi.org/10.3390/cancers15184478
AMA Style
Davy M, Genest L, Legrand C, Pelouin O, Froget G, Castagné V, Rupp T.
Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models. Cancers. 2023; 15(18):4478.
https://doi.org/10.3390/cancers15184478
Chicago/Turabian Style
Davy, Mélodie, Laurie Genest, Christophe Legrand, Océane Pelouin, Guillaume Froget, Vincent Castagné, and Tristan Rupp.
2023. "Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models" Cancers 15, no. 18: 4478.
https://doi.org/10.3390/cancers15184478
APA Style
Davy, M., Genest, L., Legrand, C., Pelouin, O., Froget, G., Castagné, V., & Rupp, T.
(2023). Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models. Cancers, 15(18), 4478.
https://doi.org/10.3390/cancers15184478